Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

E-Poster Display

676P - Prognostic role of nutritional status (NS) for health-related quality of life (HRQoL) in men with advanced prostate cancer

Date

17 Sep 2020

Session

E-Poster Display

Topics

Tumour Site

Prostate Cancer

Presenters

Luka Cavka

Citation

Annals of Oncology (2020) 31 (suppl_4): S507-S549. 10.1016/annonc/annonc275

Authors

L. Cavka1, M. Pohar Perme2, B. Zakotnik1, N. Rotovnik Kozjek3, B. Seruga1

Author affiliations

  • 1 Department For Medical Oncology, Institute of Oncology Ljubljana, 1000 - Ljubljana/SI
  • 2 Institute For Biostatistics And Medical Informatics, Faculty of Medicine Ljubljana, 1000 - Ljubljana/SI
  • 3 Department For Clinical Nutrition, Institute of Oncology, 1000 - Ljubljana/SI

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 676P

Background

Poor baseline nutritional status (NS) is associated with worse HRQoL in patients with metastatic castrate-resistant prostate cancer (mCRPC). Here, we hypothesized that baseline NS remains prognostic for HRQoL six months later.

Methods

We prospectively enrolled men with early mCRPC who started systemic therapy for mCRPC. Based on established criteria, four NS categories were defined: normal NS (nNS), nutritional risk without cachexia/sarcopenia (NR), sarcopenia (S) (handgrip strength <30 kg) and cachexia (C) (Evans`s criteria). HRQoL after six months was measured by the validated questionnaire Functional Assessment of Cancer Treatment (FACT-P). To overcome the problem of dropping out of patients, a sensitivity analysis was performed. Based on a cutoff of 75% total score of FACT-P, patients were categorized into two groups (either good or poor HRQoL). Patients who dropped out because of the disease-related reason were allocated into the poor HRQoL group, while those without known reason of dropping out either into good (conservative case scenario) or poor (liberal case scenario) HRQoL group. Association between NS and HRQoL and was sought in the model of logistic regression.

Results

One hundred forty-one patients were enrolled in our study. At presentation, their mean age was 74.1 years (SD 7.3). Of these 87 (61.7%) and 27 (19.1%) were started on modern hormonal therapy and chemotherapy, respectively. After six months 47 (33.3%) patients dropped out. We found a significant negative prognostic value of NR and cachexia for HRQoL at six months in both case scenarios (for conservative case scenario OR was 0.29 and 0.22; with 95% CI [0.11 to 0.81] and [0.07 to 0.74], respectively). Prognostic value of sarcopenia was non-significant in both case scenarios.

Conclusions

Poor NS has a durable unfavorable impact on HRQoL in men with mCRPC. Early nutritional support is warranted in these patients.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Bostjan Seruga.

Funding

Slovenian Research Agency.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.